OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA OIP5-AS1 promotes cell proliferation and migration and induces angiogenesis via regulating miR-3163/VEGFA in hepatocellular carcinoma
Changsheng Shi, Qing Yang, Songsong Pan, et al.
Cancer Biology & Therapy (2020) Vol. 21, Iss. 7, pp. 604-614
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Involvement of Long Non-Coding RNAs (lncRNAs) in Tumor Angiogenesis
Julia Teppan, Dominik A. Barth, Felix Prinz, et al.
Non-Coding RNA (2020) Vol. 6, Iss. 4, pp. 42-42
Open Access | Times Cited: 43

Exosomes Derived from Human Amniotic Mesenchymal Stem Cells Facilitate Diabetic Wound Healing by Angiogenesis and Enrich Multiple lncRNAs
Shangfeng Fu, Hongyan Zhang, Xiancai Li, et al.
Tissue Engineering and Regenerative Medicine (2023) Vol. 20, Iss. 2, pp. 295-308
Closed Access | Times Cited: 16

Long non-coding RNAs in hepatocellular carcinoma
Wenjun Ge, Huan Huang, Tao Wang, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154604-154604
Closed Access | Times Cited: 15

An angiogenesis-related three-long non-coding ribonucleic acid signature predicts the immune landscape and prognosis in hepatocellular carcinoma
Wenjuan Wang, Yingquan Ye, Xuede Zhang, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13989-e13989
Open Access | Times Cited: 13

Long non‐coding RNA OIP5‐AS1 (Cyrano): A context‐specific regulator of normal and disease processes
Serena Wooten, Keriayn N. Smith
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20

The role of lncRNA OIP5-AS1 in cancer development and progression
Cheng Zheng, Man Chu, Qiuli Chen, et al.
APOPTOSIS (2022) Vol. 27, Iss. 5-6, pp. 311-321
Closed Access | Times Cited: 20

Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
Zhao-Shan Niu, Wenhong Wang, Xiao-Jun Niu
World Journal of Gastroenterology (2022) Vol. 28, Iss. 46, pp. 6433-6477
Open Access | Times Cited: 20

Exosomal lncRNAs in the Tumor Angiogenesis: As Therapeutic Targets in Cancer Treatment
Chou‐Yi Hsu, Farag M. A. Altalbawy, Enwa Felix Oghenemaro, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 4
Closed Access

Investigation of circulating lncRNAs as potential biomarkers in chronic respiratory diseases
Zsófia Gál, András Gézsi, Ágnes F. Semsei, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 25

The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities
Ilaria Saltarella, Benedetta Apollonio, Aurelia Lamanuzzi, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 1963-1963
Open Access | Times Cited: 16

LncRNA OIP5-AS1 reduces renal epithelial cell apoptosis in cisplatin-induced AKI by regulating the miR-144-5p/PKM2 axis
Siyuan Chang, Ming‐Yang Chang, Gang Liu, et al.
Biomedical Journal (2021) Vol. 45, Iss. 4, pp. 642-653
Open Access | Times Cited: 16

CircSNX6 promotes proliferation, metastasis, and angiogenesis in hepatocellular carcinoma via miR-383-5p/VEGFA signaling pathway
Yuan Tian, Wenwen Han, Kaiji Lv, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

Exploring IDI2-AS1, OIP5-AS1, and LITATS1: Changes in Long Non-coding RNAs Induced by the Poly I:C Stimulation
Yuka Yagi, Rina Abe, Hidenori Tani
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 6, pp. 1144-1147
Open Access | Times Cited: 2

<p>Long Noncoding RNA PRR34-AS1 Aggravates the Progression of Hepatocellular Carcinoma by Adsorbing microRNA-498 and Thereby Upregulating FOXO3</p>
Zhaoming Liu, Zhen Li, Binghui Xu, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 10749-10762
Open Access | Times Cited: 18

Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways
Mehrdad Hashemi, Sophie Mousavian Roshanzamir, Mahshid Deldar Abad Paskeh, et al.
European Journal of Pharmacology (2023) Vol. 941, pp. 175380-175380
Closed Access | Times Cited: 6

Role of Some microRNA/ADAM Proteins Axes in Gastrointestinal Cancers as a Novel Biomarkers and Potential Therapeutic Targets—A Review
Agnieszka Kalita, Magdalena Sikora-Skrabaka, Ewa Nowakowska‐Zajdel
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 2917-2936
Open Access | Times Cited: 6

Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma
Mohamed H. Yousef, Hassan A. N. El‐Fawal, Anwar Abdelnaser
BioMed Research International (2020) Vol. 2020, pp. 1-30
Open Access | Times Cited: 15

MSC-AS1 induced cell growth and inflammatory mediators secretion through sponging miR-142-5p/DDX5 in gastric carcinoma
Yan Liu, Li Lin, Xiaoxu Wu, et al.
Aging (2021) Vol. 13, Iss. 7, pp. 10387-10395
Open Access | Times Cited: 14

LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway
Yi-Pin CAI, Yu Huang, Jie Zhang, et al.
Neoplasma (2022) Vol. 69, Iss. 06, pp. 1406-1417
Open Access | Times Cited: 9

Research progress on the role of RNA N6-methyladenosine methylation in HCV infection
Yiyang Ge, Shi Tang, Tian Xia, et al.
Virology (2023) Vol. 582, pp. 35-42
Open Access | Times Cited: 5

Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta‐analysis
Jiading Qin, Bo Ke, Tingting Liu, et al.
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 2199-2218
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top